Latest Breaking News On - Retrophin inc - Page 3 : comparemela.com

Obsessive-Compulsive Disorder (OCD) Pipeline Analysis

Obsessive-Compulsive Disorder (OCD) Pipeline Analysis
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Roche pharmaceuticalsRetrophin incPfizer incBehavior analysis incAutism services incGlobal autism spectrum disorderAutism treatment plusBehavior analysisAutism therapeutics

Zevra Names New CEO

Zevra Therapeutics Inc announced that Neil McFarlane has been hired as president and CEO and appointed to the board of directors.

United statesChristal mickleTamara seymour favoritoNeil mcfarlaneJoseph saluriAdamas pharmaceuticals incUnited states armyZevra therapeutics incSangstat medical corporationSupernus pharmaceuticals incGenzyme corporationUniversity of floridaTravere therapeutics incCollegium pharmaceutical incRetrophin incSupernus pharmaceuticals

Zevra Therapeutics Names Neil McFarlane President, CEO

(RTTNews) - Zevra Therapeutics, Inc. (ZVRA), a rare disease therapeutics company, announced Tuesday the appointment of Neil McFarlane as President.

Joseph saluriChristal mickleBoard of directors adamas pharmaceuticals incSupernus pharmaceuticals incTravere therapeutics incGenzyme corpUcb incZevra therapeutics incDevelopment officerCollegium pharmaceutical incRetrophin incMore such health newsSangstat medical corpNeil mcfarlaneChief executive officerChief development

Zevra Therapeutics Appoints Neil F McFarlane as President, Chief Executive Officer and Director

Zevra Therapeutics Appoints Neil F McFarlane as President, Chief Executive Officer and Director
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesChristalmm mickleNichol ochsnerJoe saluriJanine bogrisTamaraa seymour favoritoNeilf mcfarlaneJosephb saluriChristal mickleRetrophin incUniversity of floridaTravere therapeutics incCompensation committee of zevra board directorsDevelopment officerUnited states armySangstat medical corporation

Phenylketonuria Therapeutics Sector Poised for 8 6% CAGR Augmentation by 2033, According to Future M

A genetic metabolic condition called Phenylketonuria Therapeutics Market affects how the body processes protein. Phenylalanine is an amino acid that patients with PKU are unable to effectively break down, which can result in the accumulation of harmful chemicals in the body. PKU can result in severe intellectual dis.

New yorkUnited statesErytech pharmaMarket insights incCensa pharmaceuticalsRetrophin incCodexis incGreater new york chamberHomology medicines incPhenylketonuria therapeutics industrySynthetic biologics incBiomarin pharmaceuticalsRoute of administrationPhenylketonuria therapeutics marketExclusive reportSpectacular growth